These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18427281)

  • 1. Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.
    Ehrlich JR; Ocholla H; Ziemek D; Rütten H; Hohnloser SH; Gögelein H
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):380-7. PubMed ID: 18427281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
    Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
    Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
    Wirth KJ; Brendel J; Steinmeyer K; Linz DK; Rütten H; Gögelein H
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):197-206. PubMed ID: 17438404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
    Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
    Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin and simvastatin on atrial plateau currents.
    Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Delpón E
    J Mol Cell Cardiol; 2007 May; 42(5):931-45. PubMed ID: 17466325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
    Gögelein H; Brendel J; Steinmeyer K; Strübing C; Picard N; Rampe D; Kopp K; Busch AE; Bleich M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):183-92. PubMed ID: 15340774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
    Núñez L; Vaquero M; Gómez R; Caballero R; Mateos-Cáceres P; Macaya C; Iriepa I; Gálvez E; López-Farré A; Tamargo J; Delpón E
    Cardiovasc Res; 2006 Oct; 72(1):80-9. PubMed ID: 16876149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
    Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.
    Blass BE; Fensome A; Trybulski E; Magolda R; Gardell SJ; Liu K; Samuel M; Feingold I; Huselton C; Jackson CM; Djandjighian L; Ho D; Hennan J; Janusz JM
    J Med Chem; 2009 Nov; 52(21):6531-4. PubMed ID: 19888755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
    Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
    Jeong I; Choi BH; Yoon SH; Hahn SJ
    Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
    Yang Z; Browning CF; Hallaq H; Yermalitskaya L; Esker J; Hall MR; Link AJ; Ham AJ; McGrath MJ; Mitchell CA; Murray KT
    Cardiovasc Res; 2008 Jun; 78(3):449-57. PubMed ID: 18281375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of a time-dependent potassium current in pig atrium: evidence for a role of kv1.5 in repolarization.
    Ehrlich JR; Hoche C; Coutu P; Metz-Weidmann C; Dittrich W; Hohnloser SH; Nattel S; Gögelein H
    J Pharmacol Exp Ther; 2006 Nov; 319(2):898-906. PubMed ID: 16916995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres.
    Friedrich O; V Wegner F; Wink M; Fink RH
    Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5.
    Zhang X; Anderson JW; Fedida D
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1247-56. PubMed ID: 9190860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.